Company Profile
Updated: 29-SEP-09OXiGENE Inc.
Public Company, Headquarters Location
230 3rd Ave., Waltham, MA 02451-7528, United States
(781)547-5900, (781)547-6800 fax, http://www.oxigene.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Research and development of products for use in the treatment of cancer.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
OXIGENE REPORTS ACQUISITION BY DIRECTOR FICKLING (California)
US Fed News Service, Including US State News; 12/15/2009; 297 words; WASHINGTON, Dec. 15 -- OXiGENE Inc. (OXGN), South San Francisco, Calif., has filed a Form 4 with the Securities and Exchange Commission noting the change in...
OXIGENE REPORTS ACQUISITION BY DIRECTOR SHIEBLER (California)
US Fed News Service, Including US State News; 12/15/2009; 304 words; WASHINGTON, Dec. 15 -- OXiGENE Inc. (OXGN), South San Francisco, Calif., has filed a Form 4 with the Securities and Exchange Commission noting the change in...
Oxigene announces good preclinical data for AML drug candidate.
Nordic Business Report; 12/8/2009; 628 words; NORDIC BUSINESS REPORT-8 December 2009-Oxigene announces good preclinical data for AML drug candidate...December 2009 - Stockholm-listed biopharmaceutical company Oxigene Inc (STO: OXGN) said today that its drug candidate OXi4503...
Stockholm-listed Oxigene announces positve preclinical data for AML drug.
ADP News Nordic; 12/8/2009; 681 words; (ADPnews) - Dec 8, 2009 - Stockholm-listed biopharmaceutical company Oxigene Inc (STO:OXGN) said today that its drug candidate OXi4503 for treatment of acute myelogenous leukemia (AML) has showed positive...
FORM 8-K: VAXGEN ANNOUNCES DEFINITIVE AGREEMENT
US Fed News Service, Including US State News; 11/21/2009; 1105 words; ...members of the VaxGen board of directors, OXiGENE, Inc. ("OXiGENE") and OXiGENE Merger Sub, Inc. ("Merger Sub...SEC by OXiGENE by directing a written request to OXiGENE, Inc., 701 Gateway Boulevard, Suite 210, South San...
Recent News Articles
- News and FDA Updates for Compugen (NASDAQ:CGEN), OXiGENE, Inc. (Nasdaq:OXGN), Generex (Nasdaq:GNBT), and MediciNova, Inc., (Nasdaq:MNOV).
M2 Presswire - July 22, 2009 - FDA and News Updates for Pfizer Inc.(NYSE:PFE), OXiGENE, Inc. (Nasdaq:OXGN), Cadence (Nasdaq: CADX) and PolyMedix, Inc. (OTC: PYMX).
M2 Presswire - July 16, 2009 - Q4 2008 OXiGENE, Inc. Earnings Conference Call - Final.(Broadcast transcript)
Fair Disclosure Wire - February 26, 2009 - OXiGENE INC-Financial Company Report.
M2 Presswire - February 18, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning